Total Return chart Alzinova AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2026-07-10 EDT			5-day change	1st Jan Change
0.7000 ^SEK	-23.08%		+41.41%	-15.56%

06-24	Alzinova AB and Fujirebio Enter Letter of Intent for Potential Commercialization of Blood-Based Alzheimer?S Diagnostic Test	CI
06-24	Alzinova Inks Nonbinding Deal with Fujirebio for Potential Alzheimer's Blood-based Diagnostic Test	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.